Back
Arca Continental SAB de CV Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Buy
58
EMBVF
Arca Continental SAB de CV
Last Price:
$10.55
Seasonality Move:
5.8%
Sell
32
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.71
Seasonality Move:
-18.07%
Buy
58
Arca Continental SAB de CV (EMBVF)
is a Buy
Is Arca Continental SAB de CV a Buy, Sell or Hold?
-
The current Arca Continental SAB de CV [EMBVF] share price is $10.55. The Score for EMBVF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
EMBVF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.71. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EMBVF Stock Price Chart
What is Arca Continental SAB de CV's stock price today?
-
The Arca Continental SAB de CV share price today is $10.55The current trend is moderately bullish and EMBVF is experiencing slight buying pressure.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.
EMBVF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 58.18 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.88 - 10.48) | Buy |
| Bollinger Bands (100): | (9.83 - 10.53) | Buy |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 45.61 | Sell |
| Chaikin Money Flow: | -20975 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.89 - 12.65) | Sell |
| Bollinger Bands (100): | (12.3 - 15.28) | Sell |
EMBVF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.49 | Buy |
| 20-day SMA: | 10.19 | Buy |
| 50-day SMA: | 9.97 | Buy |
| 200-day SMA: | 10.34 | Buy |
| 8-day EMA: | 10.51 | Buy |
| 20-day EMA: | 10.3 | Buy |
| 50-day EMA: | 10.15 | Buy |
| 200-day EMA: | 10.12 | Buy |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.32 | Sell |
| 20-day SMA: | 11.56 | Buy |
| 50-day SMA: | 12.92 | Sell |
| 200-day SMA: | 11.86 | Sell |
| 8-day EMA: | 12.05 | Sell |
| 20-day EMA: | 12.05 | Sell |
| 50-day EMA: | 12.68 | Sell |
| 200-day EMA: | 12.23 | Sell |
Arca Continental SAB de CV Earnings Growth & EMBVF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.05 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Arca Continental SAB de CV Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||